Curemark LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curemark LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0467
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, and multiple preclinical programs. Curemark’s pipeline also comprises clinical-stage and preclinical programs for treating ADHD, Parkinson’s, schizophrenia and addiction. The company partners with other biopharmaceutical and pharmaceutical companies for its drug development activities. Curemark is headquartered in Rye, New York, the US.

Curemark LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curemark LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curemark LLC, Medical Devices Deals, 2012 to YTD 2018 9
Curemark LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Curemark LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Curemark Raises USD3.2 Million in Venture Financing 11
Curemark Raises USD20 Million in Equity Financing 12
Curemark Raises USD5 Million in Venture Financing 13
Curemark Raises US$18.5 Million In Venture Financing 14
Curemark Raises US$18.8 Million In Venture Financing 15
Curemark Raises US$6 Million In Venture Financing 16
Partnerships 17
Curemark Enters Into Research Agreement With Molecular Sciences Institute 17
Acquisition 18
Shenzhen Hepalink Pharma Plans to Acquire 3.63% Stake in Curemark 18
Curemark LLC – Key Competitors 19
Curemark LLC – Key Employees 20
Curemark LLC – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Curemark LLC, Pharmaceuticals & Healthcare, Key Facts 2
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curemark LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curemark LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Curemark LLC, Medical Devices Deals, 2012 to YTD 2018 9
Curemark LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Curemark Raises USD3.2 Million in Venture Financing 11
Curemark Raises USD20 Million in Equity Financing 12
Curemark Raises USD5 Million in Venture Financing 13
Curemark Raises US$18.5 Million In Venture Financing 14
Curemark Raises US$18.8 Million In Venture Financing 15
Curemark Raises US$6 Million In Venture Financing 16
Curemark Enters Into Research Agreement With Molecular Sciences Institute 17
Shenzhen Hepalink Pharma Plans to Acquire 3.63% Stake in Curemark 18
Curemark LLC, Key Competitors 19
Curemark LLC, Key Employees 20

List of Figures
Curemark LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curemark LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curemark LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curemark LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Curemark LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Boule Diagnostics AB (BOUL):医療機器:M&Aディール及び事業提携情報
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • KCA Deutag Alpha Ltd:企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Verizon Communications Inc.:企業のM&A・事業提携・投資動向
    Verizon Communications Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Verizon Communications Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Fluor Corporation:戦略・SWOT・企業財務分析
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tellurian Inc (TELL):石油・ガス:M&Aディール及び事業提携情報
    Summary Tellurian Inc (Tellurian), formerly Magellan Petroleum Corp, is an oil and gas company that provides exploration, development, and production of crude oil and natural gas. The company develops liquefied natural gas production and export terminal on the west bank of the Calcasieu River, south …
  • Cipla Limited:企業の戦略・SWOT・財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cathay Life Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Janus Henderson Group Plc:企業の戦略・SWOT・財務情報
    Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report Summary Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Armstrong World Industries Inc (AWI):企業の財務・戦略的SWOT分析
    Armstrong World Industries Inc (AWI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lakeview Hotel Investment Corp.:戦略・SWOT・企業財務分析
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Phosphagenics Ltd:企業のM&A・事業提携・投資動向
    Phosphagenics Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Phosphagenics Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Dignitana AB (DIGN)-医療機器分野:企業M&A・提携分析
    Summary Dignitana AB (Dignitana), a subsidiary of Eurosund AB, designs, develops, and markets medical refrigeration systems. The company’s flagship product, DigniCap system offers uniform scalp cooling to reduce hair loss in patients undergoing chemotherapy. The DigniCap system consists of DigniCool …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Sagent Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • Tundra Oil & Gas Partnership:石油・ガス:M&Aディール及び事業提携情報
    Summary Tundra Oil & Gas Partnership (Tundra), a subsidiary of James Richardson & Sons, Limited is an oil and gas company that offers asset development services. The company produces and markets light sweet crude oil in southeastern Saskatchewan and southwestern Manitoba. It explores and produces na …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆